Wrapping up Q3 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including GoodRx ...

Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to ...

Surescripts is teaming up with Good Rx to surface key prescription discounts to consumers. | SAN FRANCISCO — Surescripts is ...

Analysts have recently evaluated GoodRx Holdings and provided 12-month price targets. The average target is $4.16, accompanied by a high estimate of $6.00 and a low estimate of $2.75. This current ...

Fintel reports that on January 22, 2026, Jefferies downgraded their outlook for GoodRx Holdings (NasdaqGS:GDRX) from Buy to ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is ...

Consumers can soon go to GoodRx for Weight Loss to determine eligibility and obtain a prescription for the first and only oral GLP-1 formulation GoodRx (Nasdaq: GDRX), the leading platform for ...

GoodRx's telemedicine service offers oral semaglutide for weight loss, with initial pricing of $149 for 1.5 mg and 4 mg doses, increasing to $199 for 4 mg after April 2026. Larger doses of oral ...

Eligible patients can now get the Wegovy pill — the first oral GLP-1 treatment for weight management in adults — at Hy-Vee ...

GoodRx reports on tracking prescription fills for flu and COVID-19 treatments, revealing seasonal trends and insurance ...

GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of RxSmartSaver powered by GoodRx at Giant Eagle pharmacies, giving patients a fast and easy ...

Key Insights Significant control over GoodRx Holdings by individual investors implies that the general public has ...